Boston Trust Walden Corp Raises Stake in Amdocs Limited $DOX

Boston Trust Walden Corp increased its stake in Amdocs Limited (NASDAQ:DOX) by 5.9% during the second quarter, according to its most recent filing with the SEC. The fund owned 678,929 shares of the technology company’s stock after buying an additional 37,835 shares during the quarter. Boston Trust Walden Corp’s holdings in Amdocs were worth $61,945,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in DOX. Alyeska Investment Group L.P. boosted its holdings in shares of Amdocs by 38.6% in the 1st quarter. Alyeska Investment Group L.P. now owns 2,329,767 shares of the technology company’s stock worth $213,174,000 after buying an additional 648,693 shares during the last quarter. American Century Companies Inc. boosted its holdings in shares of Amdocs by 23.5% in the 1st quarter. American Century Companies Inc. now owns 2,242,829 shares of the technology company’s stock worth $205,219,000 after buying an additional 426,911 shares during the last quarter. Nuveen LLC purchased a new position in shares of Amdocs in the 1st quarter worth about $36,921,000. LSV Asset Management boosted its holdings in shares of Amdocs by 11.1% in the 1st quarter. LSV Asset Management now owns 3,180,501 shares of the technology company’s stock worth $291,016,000 after buying an additional 317,412 shares during the last quarter. Finally, AQR Capital Management LLC boosted its holdings in shares of Amdocs by 43.0% in the 1st quarter. AQR Capital Management LLC now owns 955,158 shares of the technology company’s stock worth $86,719,000 after buying an additional 287,243 shares during the last quarter. 92.02% of the stock is owned by hedge funds and other institutional investors.

Amdocs Trading Up 0.8%

Shares of DOX opened at $81.44 on Tuesday. The business’s 50-day moving average price is $84.73 and its 200-day moving average price is $87.61. Amdocs Limited has a twelve month low of $78.61 and a twelve month high of $95.41. The stock has a market cap of $9.19 billion, a PE ratio of 16.52, a P/E/G ratio of 1.34 and a beta of 0.51. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings results on Wednesday, August 6th. The technology company reported $1.72 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.01. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The firm had revenue of $1.14 billion for the quarter, compared to analysts’ expectations of $1.13 billion. During the same period in the prior year, the business posted $1.62 earnings per share. The company’s revenue was down 8.4% on a year-over-year basis. On average, equities analysts forecast that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be given a $0.527 dividend. This represents a $2.11 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Tuesday, September 30th. Amdocs’s dividend payout ratio is 42.80%.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Amdocs in a report on Wednesday, October 8th. Wall Street Zen raised shares of Amdocs from a “hold” rating to a “buy” rating in a report on Saturday. Finally, Wolfe Research assumed coverage on shares of Amdocs in a report on Tuesday, July 8th. They set an “outperform” rating on the stock. Three research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $108.00.

Amdocs Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.